This randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.
Adult patients (aged 18 years and older) undergoing allogeneic HSCT and are approaching 100-days post-HSCT
Ability to speak, read, and respond to questions in English or Spanish to complete study procedures
Access to a basic telephone
Patients who underwent allogeneic HSCT for benign hematologic conditions
Patients with severe psychiatric or cognitive conditions, such as dementia, determined by their transplant oncologist to make them unable to provide informed consent or comply with study procedures
Brigham and Women's Hospital
Lead sponsor
Dana-Farber Cancer Institute
Collaborator
Duke University
Collaborator
H. Lee Moffitt Cancer Center and Research Institute
Collaborator